Literature DB >> 2271512

Urinary plasminogen activator activity in progressive renal failure.

S Y Hong1, D H Yang.   

Abstract

The purpose of this study was to discover how functional nephrons produce the plasminogen activator as renal function progresses to renal failure. Urine Plasminogen activator (U-PA) activity was measured by the fibrin plate method in 73 patients with various degrees of renal function deterioration from various underlying diseases and in one healthy individual in order to evaluate the plasminogen activator activity of remnant nephrons. The plasminogen activator activity of the 12 consecutive urine samples from the healthy individual showed that is varied according to the time of day, but there was no circadian rhythm. The urine plasminogen activator activity correlated with the osmolality (r = 0.51, P less than 0.001) and creatinine (r = 0.56, P less than 0.001) of the urine, suggesting that it is concentrated at distal nephrons. The fractional sodium excretion rate (FeNa) increased abruptly when GFR decreased below 25 L/day. This pattern was very similar with the relation between total U-PA activity/GFR and GFR. The correlation between total U-PA activity and FeNa was not significant, but there was a significant direct correlation between total U-PA activity/GFR and FeNa (r = 0.775, P less than 0.0001). There was no relationship between the 24-hour urine protein and total U-PA activity or total U-PA activity/GFR.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2271512      PMCID: PMC4534997          DOI: 10.3904/kjim.1990.5.1.58

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  18 in total

1.  Cortical fibrinolytic activity in normal and diseased human kidneys.

Authors:  J M Bergstein; A F Michael
Journal:  J Lab Clin Med       Date:  1972-05

2.  Discontinuities (gaps) of the glomerular capillary wall and basement membrane in renal diseases.

Authors:  J Stejskal; C L Pirani; M Okada; N Mandelanakis; V E Pollak
Journal:  Lab Invest       Date:  1973-02       Impact factor: 5.662

3.  Urokinase excretion in chronic renal diseases of different histological types.

Authors:  F Asbeck; E Sistig; E Renner; H G Sieberth; J van de Loo
Journal:  Clin Nephrol       Date:  1973 Jan-Feb       Impact factor: 0.975

4.  The isolation and characterization of plasminogen activators (urokinase) from human urine.

Authors:  W F White; G H Barlow; M M Mozen
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

5.  On coagulation and fibrinolysis in conservatively treated chronic uraemia.

Authors:  S O Larsson; U Hedner; I M Nilsson
Journal:  Acta Med Scand       Date:  1971-06

6.  Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance.

Authors:  K S Kant; V E Pollak; M A Weiss; H I Glueck; A N Miller; E V Hess
Journal:  Medicine (Baltimore)       Date:  1981-03       Impact factor: 1.889

7.  Urokinase excretion in patients with renal diseases.

Authors:  J Vreeken; J Boomgaard; K Deggeller
Journal:  Acta Med Scand       Date:  1966-08

8.  Defibrination with ancrod in glomerulonephritis: effects on clinical and histologic findings and on blood coagulation.

Authors:  V E Pollak; H I Glueck; M A Weiss; A Lebron-Berges; M A Miller
Journal:  Am J Nephrol       Date:  1982       Impact factor: 3.754

9.  Glomerular fibrinolytic activity following endotoxin-induced glomerular fibrin deposition in the pregnant rat.

Authors:  J M Bergstein; J R Hoyer; A F Michael
Journal:  Am J Pathol       Date:  1974-04       Impact factor: 4.307

10.  Purification and characterization of human vascular plasminogen activator.

Authors:  B Aasted
Journal:  Biochim Biophys Acta       Date:  1980-02-27
View more
  1 in total

1.  The urine urokinase concentration in end stage renal disease with acquired renal cyst.

Authors:  S Y Hong; D H Yang; B H Lee; E K Ki; K H Chung
Journal:  Korean J Intern Med       Date:  1991-07       Impact factor: 2.884

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.